AMN Healthcare Services Inc. Files Q3 2024 10-Q

TL;DR

AMN Healthcare's Q3 2024 10-Q is in. Check financials.

AI Summary

AMN Healthcare Services Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the healthcare staffing sector.

Why It Matters

This filing provides investors and analysts with the latest financial performance data for AMN Healthcare Services Inc., crucial for understanding the company's current health and future prospects in the healthcare staffing market.

Risk Assessment

Risk Level: medium — The filing is a routine quarterly report, but the healthcare staffing industry can be subject to regulatory changes and labor market fluctuations.

Key Numbers

• Q3 2024 — Reporting Period (The company's financial performance for the third quarter of 2024 is detailed.)
• 2024-09-30 — Period End Date (This is the date through which the financial information in the 10-Q is reported.)
• 2024-11-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• AMN HEALTHCARE SERVICES INC (company) — Filer of the 10-Q
• 2024-09-30 (date) — End of the reporting period
• 2024-11-08 (date) — Filing date of the 10-Q
• 7363 (number) — Standard Industrial Classification code for Help Supply Services
• DE (state) — State of incorporation
• DALLAS (city) — Business and mailing address city
• TX (state) — Business and mailing address state
• 75019 (zip_code) — Business and mailing address zip code

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value AMN New York Stock Exchange

Filing Documents

• amn-20240930.htm (10-Q) — 1250KB
• amn-ex41x20240930x10q.htm (EX-4.1) — 64KB
• amn-ex101x20240930x10xq.htm (EX-10.1) — 69KB
• amn-ex102x20240930x10xq.htm (EX-10.2) — 77KB
• amn-ex311x20240930x10q.htm (EX-31.1) — 11KB
• amn-ex312x20240930x10q.htm (EX-31.2) — 11KB
• amn-ex321x20240930x10q.htm (EX-32.1) — 6KB
• amn-ex322x20240930x10q.htm (EX-32.2) — 6KB
• amn-20240930_g1.jpg (GRAPHIC) — 49KB
• 0001142750-24-000061.txt ( ) — 6884KB
• amn-20240930.xsd (EX-101.SCH) — 32KB
• amn-20240930_cal.xml (EX-101.CAL) — 77KB
• amn-20240930_def.xml (EX-101.DEF) — 138KB
• amn-20240930_lab.xml (EX-101.LAB) — 513KB
• amn-20240930_pre.xml (EX-101.PRE) — 352KB
• amn-20240930_htm.xml (XML) — 1170KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1. Condensed Consolidated Financial Statements (unaudited): 1 Condensed Consolidated Balance Sheets, As of September 30, 2024 and December 31, 2023 1 Condensed Consolidated Statements of Comprehensive Income, For the Three and Nine Months Ended September 30, 2024 and 2023 2 Condensed Consolidated Statements of Stockholders' Equity, For the Nine Months Ended September 30, 2024 and 2023 3 Condensed Consolidated Statements of Cash Flows, For the Nine Months Ended September 30, 2024 and 2023 4 Notes to Unaudited Condensed Consolidated Financial Statements 6 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17 3. Quantitative and Qualitative Disclosures about Market Risk 27 4. Controls and Procedures 27

- OTHER INFORMATION

PART II - OTHER INFORMATION 1. Legal Proceedings 28 1A. Risk Factors 28 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 3. Defaults Upon Senior Securities 28 4. Mine Safety Disclosures 28 5. Other Information 28 6. Exhibits 29

Signatures

Signatures 30 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements AMN HEALTHCARE SERVICES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands, except par value) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 30,550 $ 32,935 Accounts receivable, net of allowances of $ 31,199 and $ 32,233 at September 30, 2024 and December 31, 2023, respectively 451,062 623,488 Accounts receivable, subcontractor 68,566 117,703 Prepaid expenses 17,073 21,889 Other current assets 45,015 45,670 Total current assets 612,266 841,685 Restricted cash, cash equivalents and investments 72,167 68,845 Fixed assets, net of accumulated depreciation of $ 341,040 and $ 285,081 at September 30, 2024 and December 31, 2023, respectively 196,902 191,385 Other assets 267,266 236,796 Goodwill 1,116,815 1,111,549 Intangible assets, net of accumulated amortization of $ 513,785 and $ 442,052 at September 30, 2024 and December 31, 2023, respectively 402,400 474,134 Total assets $ 2,667,816 $ 2,924,394 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 213,206 $ 343,847 Accrued compensation and benefits 281,683 278,536 Other current liabilities 23,657 33,738 Total current liabilities 518,546 656,121 Revolving credit facility 285,000 460,000 Notes payable, net of unamortized fees and premium 845,576 844,688 Deferred income taxes, net 17,270 23,350 Other long-term liabilities 110,759 108,979 Total liabilities 1,777,151 2,093,138 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; 10,000 shares authorized; none issued and outstanding at September 30, 2024 and December 31, 2023 — — Common stock, $ 0.01 par value; 200,000 shares authorized; 50,631 issued and 38,018 outstanding at September 30, 2024 and 50,423 issued and 37,810 outstanding at December 31, 2023 506 504 Additional paid-in capital 525,029 506,543 Treasury stock, at cost; 12,613 sh

View Full Filing

View this 10-Q filing on SEC EDGAR